Anthropic’s rapid ascent to a $965 billion valuation via its May 2026 Series H round, combined with a confidential June IPO filing targeting an October Nasdaq debut, anchors trader expectations around the $1.25–1.75 trillion range. Strong enterprise adoption—recently surpassing OpenAI in U.S. business AI spending share—along with Claude’s benchmark-leading performance in coding and long-context tasks and a safety-focused positioning have driven annualized revenue past $47 billion. This momentum, set against OpenAI’s own scale and Microsoft distribution, creates a closely contested outcome where IPO pricing will hinge on disclosed financials and broader AI capital-market appetite.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano$1.25–$1.50T 46%
$1.50–$1.75T 43%
<$1.25T 37%
$1.75–$2.00T 33%
<$1.25T
37%
$1.25–$1.50T
46%
$1.50–$1.75T
43%
$1.75–$2.00T
33%
$2.00–$2.25T
13%
$2.25–$2.50T
9%
$2.50T+
9%
No IPO by December 31, 2027
6%
$1.25–$1.50T 46%
$1.50–$1.75T 43%
<$1.25T 37%
$1.75–$2.00T 33%
<$1.25T
37%
$1.25–$1.50T
46%
$1.50–$1.75T
43%
$1.75–$2.00T
33%
$2.00–$2.25T
13%
$2.25–$2.50T
9%
$2.50T+
9%
No IPO by December 31, 2027
6%
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
Rynek otwarty: Aug 19, 2026, 9:45 AM ET
Resolver
0x69c47De9D...The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
Resolver
0x69c47De9D...Anthropic’s rapid ascent to a $965 billion valuation via its May 2026 Series H round, combined with a confidential June IPO filing targeting an October Nasdaq debut, anchors trader expectations around the $1.25–1.75 trillion range. Strong enterprise adoption—recently surpassing OpenAI in U.S. business AI spending share—along with Claude’s benchmark-leading performance in coding and long-context tasks and a safety-focused positioning have driven annualized revenue past $47 billion. This momentum, set against OpenAI’s own scale and Microsoft distribution, creates a closely contested outcome where IPO pricing will hinge on disclosed financials and broader AI capital-market appetite.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania